Mechanistic studies dissecting the low-complexity domains and condensate behavior argue for nonidentical roles of YTHDF1 and YTHDF2, while cancer models continue to implicate IGF2BPs in stabilizing drug-resistance transcripts (e.g., ABCB1). The gene discussed is YTHDF1; the disease is cancer.